UPDATE 1-FDA extends review of Alexza product by 3 months
January 23, 2012 at 09:16 AM EST
Jan 23 (Reuters) - Alexza Pharmaceuticals Inc said U.S. health regulators extended the review date for its Adasuve product by three months after the company amended its approval application for the anti-agitation treatment.
